Literature DB >> 18433912

A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.

Maja D Jesić1, Silvija Sajić, Milos M Jesić, Monika Maringa, Dragan Micić, Svetislav Necić.   

Abstract

We describe a girl aged 10.5 years with hyperglycemia, whose mother and maternal father had insulin treated diabetes since adolescence. Using genetic analysis in mother and child, we identified identical new mutation of the HNF-1alpha sequence. Treatment with small doses of sulphonylurea was initiated and that therapy gave good results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433912     DOI: 10.1016/j.diabres.2008.03.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

Review 1.  Personalized medicine in diabetes mellitus: current opportunities and future prospects.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

2.  Genetic determinants predicting efficacy of glucose-lowering drugs?: a long way to go ...

Authors:  Michael A Nauck; Irfan Vardarli
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 17.152

Review 3.  Precision Diabetes Is Slowly Becoming a Reality.

Authors:  Viswanathan Mohan; Venkatesan Radha
Journal:  Med Princ Pract       Date:  2019-01-27       Impact factor: 1.927

4.  Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young.

Authors:  Abdelhadi M Habeb; Elizabeth T George; Verghese Mathew; Andrew L Hattersley
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.